US Patent Issued to Hoffmann-La Roche on Oct. 14 for "Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules" (Swiss, German Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,812, issued on Oct. 14, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules" was invented by Maria Amann (Duebendorf, Switzerland), Peter Bruenker (Hittnau, Switzerland), Christina Claus (Ennetbaden, Switzerland), Claudia Ferrara Koller (Zug, Switzerland), Sandra Grau-Richards (Birmensdorf, Switzerland), Christian Klein (Bonstetten, Switzerland), Viktor Levitski (Schlieren, Switzerland), Ekkehard Moessner (Kreuzlingen, Switzerland), Joerg Thomas Regula (Munich) and Pablo Umana (Wollerau, Switzerland).

According to the abstract* released by th...